NB-UVB irradiation attenuates inflammatory response in psoriasis

Area of Science:

• Dermatology
• Immunology
• Photomedicine

Background:

• Psoriasis is a chronic inflammatory skin condition linked to immune system dysregulation and vasodilation.
• Inflammation in psoriasis is often triggered by factors activating the NF-κB pathway.
• Narrow-band ultraviolet B (NB-UVB) is a recognized psoriasis treatment, but its precise molecular mechanisms require further elucidation.

Purpose of the Study:

• To investigate the molecular mechanisms underlying NB-UVB irradiation therapy for psoriasis.
• To evaluate the impact of NB-UVB on immune cell populations and inflammatory markers in a psoriasis model.

Main Methods:

• Serum samples from psoriasis patients and healthy controls were analyzed for inflammatory factors using ELISA.
• A mouse model of psoriasis was established and treated with varying doses of NB-UVB.
• Flow cytometry assessed immune cell proportions (CD4+, CD8+, CD11c+) in mouse spleens.
• RT-PCR, Western blot, and ELISA were used to measure inflammatory factor expression in mouse skin and serum.

Main Results:

• NB-UVB irradiation demonstrated a regulatory effect on inflammatory factor expression in psoriasis patients.
• High-dose NB-UVB significantly reduced imiquimod (IMQ)-induced psoriasis-like dermatitis in mice.
• NB-UVB treatment inhibited the expression of key pro-inflammatory factors in the mouse model.

Conclusions:

• NB-UVB irradiation can modulate inflammatory factor expression, offering a therapeutic benefit for psoriasis.
• The findings suggest NB-UVB attenuates psoriasis plaques by regulating immune responses and inflammatory pathways.